903 related articles for article (PubMed ID: 18951117)
21. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
22. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy.
Lapolla A; Dalfrà MG; Masin M; Bruttomesso D; Piva I; Crepaldi C; Tortul C; Dalla Barba B; Fedele D
Acta Diabetol; 2003 Sep; 40(3):143-9. PubMed ID: 14605971
[TBL] [Abstract][Full Text] [Related]
23. Metabolic control with insulin pump therapy: the Waikato experience.
Reda E; Von Reitzenstein A; Dunn P
N Z Med J; 2007 Jan; 120(1248):U2401. PubMed ID: 17277817
[TBL] [Abstract][Full Text] [Related]
24. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.
Radermecker RP; Scheen AJ
Diabetes Metab Res Rev; 2004; 20(3):178-88. PubMed ID: 15133748
[TBL] [Abstract][Full Text] [Related]
25. [Hypoglycemia in patients treated with an external insulin pump].
Laurent JC; Waeber G; Ruiz J; Carron PN
Rev Med Suisse; 2011 Jan; 7(278):166-9. PubMed ID: 21400952
[TBL] [Abstract][Full Text] [Related]
26. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
[TBL] [Abstract][Full Text] [Related]
27. Indications for insulin pump therapy in different age groups: an analysis of 1,567 children and adolescents.
Kapellen TM; Heidtmann B; Bachmann J; Ziegler R; Grabert M; Holl RW
Diabet Med; 2007 Aug; 24(8):836-42. PubMed ID: 17650157
[TBL] [Abstract][Full Text] [Related]
28. [Insulin therapy by insulin pump: continuous or conventional self-blood glucose monitoring? ].
Renard E
Diabetes Metab; 2003 Apr; 29(2 Pt 2):S54-62. PubMed ID: 12746628
[TBL] [Abstract][Full Text] [Related]
29. Reassessment of external insulin infusion pumps.
Hotta SS; Adams D
Health Technol Assess Rep; 1990; (9):1-9. PubMed ID: 2129578
[TBL] [Abstract][Full Text] [Related]
30. Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections.
Meneghini L; Sparrow-Bodenmiller J
Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S109-14. PubMed ID: 20515298
[TBL] [Abstract][Full Text] [Related]
31. [Intensified insulin therapy and insulin micro-pumps during pregnancy].
Galuppi V
Minerva Endocrinol; 1994 Jun; 19(2):79-83. PubMed ID: 7968932
[TBL] [Abstract][Full Text] [Related]
32. Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique.
Bevier WC; Zisser H; Palerm CC; Finan DA; Seborg DE; Doyle FJ; Wollitzer AO; Jovanovic L
Diabetes Metab Res Rev; 2007 Sep; 23(6):472-8. PubMed ID: 17315240
[TBL] [Abstract][Full Text] [Related]
33. The transition from insulin infusions to long-term diabetes therapy: the argument for insulin analogs.
Braithwaite SS
Semin Thorac Cardiovasc Surg; 2006; 18(4):366-78. PubMed ID: 17395034
[TBL] [Abstract][Full Text] [Related]
34. Unlocking the opportunity of tight glycaemic control. Far from goal.
Del Prato S
Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S1-4. PubMed ID: 16135133
[TBL] [Abstract][Full Text] [Related]
35. Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy.
Pfützner J; Forst T; Butzer R; Forst S; Weber MM; Pfützner AH; Pfützner A
Diabet Med; 2006 Oct; 23(10):1124-9. PubMed ID: 16978378
[TBL] [Abstract][Full Text] [Related]
36. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
Eugster EA; Francis G;
Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
[TBL] [Abstract][Full Text] [Related]
37. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
38. Practical pearls in insulin pump therapy.
Hirsch IB
Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S23-7. PubMed ID: 20515302
[TBL] [Abstract][Full Text] [Related]
39. Continuous subcutaneous insulin infusion: Special needs for children.
Adolfsson P; Ziegler R; Hanas R
Pediatr Diabetes; 2017 Jun; 18(4):255-261. PubMed ID: 28425167
[TBL] [Abstract][Full Text] [Related]
40. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study.
Berhe T; Postellon D; Wilson B; Stone R
Pediatrics; 2006 Jun; 117(6):2132-7. PubMed ID: 16740857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
